# A Study of Tadalafil (LY450190) in Chinese Men With Erectile Dysfunction

> **NCT02224846** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 635 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** Tadalafil

## Key facts

- **NCT ID:** NCT02224846
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2016-05
- **Final completion:** 2017-05
- **Target enrollment:** 635 (ACTUAL)
- **Last updated:** 2019-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02224846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02224846, "A Study of Tadalafil (LY450190) in Chinese Men With Erectile Dysfunction". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02224846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*